These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11146880)

  • 1. Estimating the selective advantage of mutant p53 tumour cells to repeated rounds of hypoxia.
    Gammack D; Byrne HM; Lewis CE
    Bull Math Biol; 2001 Jan; 63(1):135-66. PubMed ID: 11146880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and reoxygenation: a pressure for mutant p53 cell selection and tumour progression.
    Thompson KE; Royds JA
    Bull Math Biol; 1999 Jul; 61(4):759-78. PubMed ID: 17883223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of tumour cells to hypoxia: role of p53 and NFkB.
    Royds JA; Dower SK; Qwarnstrom EE; Lewis CE
    Mol Pathol; 1998 Apr; 51(2):55-61. PubMed ID: 9713587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
    Graeber TG; Osmanian C; Jacks T; Housman DE; Koch CJ; Lowe SW; Giaccia AJ
    Nature; 1996 Jan; 379(6560):88-91. PubMed ID: 8538748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and hypoxia mimetic cooperate to counteract tumor cell resistance to glucose starvation preferentially in tumor cells with mutant p53.
    Chavez-Perez VA; Strasberg-Rieber M; Rieber M
    Biochem Biophys Res Commun; 2014 Jan; 443(1):120-5. PubMed ID: 24275138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
    Harting C; Peschke P; Borkenstein K; Karger CP
    Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cell-cell interactions in a two-phase model for avascular tumour growth.
    Breward CJ; Byrne HM; Lewis CE
    J Math Biol; 2002 Aug; 45(2):125-52. PubMed ID: 12181602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
    Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
    Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
    Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B
    Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion.
    Cai Y; Xu S; Wu J; Long Q
    J Theor Biol; 2011 Jun; 279(1):90-101. PubMed ID: 21392511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.
    Nordsmark M; Alsner J; Keller J; Nielsen OS; Jensen OM; Horsman MR; Overgaard J
    Br J Cancer; 2001 Apr; 84(8):1070-5. PubMed ID: 11308256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment.
    Pan Y; Oprysko PR; Asham AM; Koch CJ; Simon MC
    Oncogene; 2004 Jun; 23(29):4975-83. PubMed ID: 15107830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
    Brown JM
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):12-4. PubMed ID: 9647614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiphase model describing vascular tumour growth.
    Breward CJ; Byrne HM; Lewis CE
    Bull Math Biol; 2003 Jul; 65(4):609-40. PubMed ID: 12875336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome.
    Lewin TD; Maini PK; Moros EG; Enderling H; Byrne HM
    Bull Math Biol; 2018 May; 80(5):1207-1235. PubMed ID: 29488054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
    van Slooten HJ; van De Vijver MJ; Borresen AL; Eyfjörd JE; Valgardsdóttir R; Scherneck S; Nesland JM; Devilee P; Cornelisse CJ; van Dierendonck JH
    J Pathol; 1999 Dec; 189(4):504-13. PubMed ID: 10629550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
    Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
    Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of cytochrome C oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death.
    Wanka C; Brucker DP; Bähr O; Ronellenfitsch M; Weller M; Steinbach JP; Rieger J
    Oncogene; 2012 Aug; 31(33):3764-76. PubMed ID: 22120717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.